Owlet (OWLT) announced a strategic partnership with PromptCare, a leading national respiratory services and durable medical equipment, or DME, provider specializing in adult and pediatric care. The partnership expands Owlet’s clinical and DME footprint across key U.S. regions and supports broader access to the company’s FDA-cleared, prescription pulse oximeter, BabySat, through established pediatric care pathways. “This partnership represents a meaningful step forward in Owlet’s DME expansion strategy,” said Jonathan Harris, president and CEO of Owlet. “PromptCare’s deep experience in pediatric respiratory care and strong relationships with children’s hospitals make them an ideal partner as we continue to scale our clinical distribution model and make an impact where it matters most.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OWLT:
- Amazon made Beta Technologies second largest stock position in Q4
- Owlet Awaits Court Decision on Derivative Settlement
- Owlet partners with webAI for personalized infant health insights
- 3 Best Stocks to Buy Today, 1/30/2026, According to Top Analysts
- Owlet price target raised to $19 from $15 at TD Cowen
